Business
Fourth Quarter and Full Year 2019 Results
Fourth Quarter and Full Year 2019 Results.
About this update from Smith & Nephew Plc
[{"type":"text","content":"\n \n \n RNS Number : 5342D\n Smith & Nephew Plc\n 20 February 2020\n \n \n \n \n Smith+Nephew Fourth Quarter and Full Year 2019 Results\n \n \n Delivering on commitments and investing for the future\n \n \n \n \n \n 20 February 2020\n \n \n \n \n \n Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, announces results for the Fourth Quarter and Year to 31 December 2019:\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Reported\n \n \n \n \n \n \n \n \n \n \n \n Trading2\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 31 Dec\n \n \n \n \n \n \n \n \n \n \n \n 31 Dec\n \n \n \n \n \n \n \n \n \n \n \n Reported\n \n \n \n \n \n \n \n \n \n \n \n 31 Dec\n \n \n \n \n \n \n \n \n \n \n \n 31 Dec\n \n \n \n \n \n \n \n \n \n \n \n Underlying\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 2019\n \n \n \n \n \n \n \n \n \n \n \n 2018\n \n \n \n \n \n \n \n \n \n \n \n growth\n \n \n \n \n \n \n \n \n \n \n \n 2019\n \n \n \n \n \n \n \n \n \n \n \n 2018\n \n \n \n \n \n \n \n \n \n \n \n growth\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n $m\n \n \n \n \n \n \n \n \n \n $m\n \n \n \n \n \n \n \n \n \n %\n \n \n \n \n \n \n \n \n \n $m\n \n \n \n \n \n \n \n \n \n $m\n \n \n \n \n \n \n \n \n \n %\n \n \n \n \n \n \n Fourth Quarter Results1\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Revenue\n \n \n \n \n \n \n \n \n \n \n \n 1,407\n \n \n \n \n \n \n \n \n \n \n \n 1,294\n \n \n \n \n \n \n \n \n \n \n \n 8.7\n \n \n \n \n \n \n \n \n \n \n \n 1,407\n \n \n \n \n \n \n \n \n \n \n \n 1,294\n \n \n \n \n \n \n \n \n \n \n \n 5.6\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n...